accesories

Apple reduces price of accessories not included in iPhone 12 box

With the introduction of iPhone 12, Apple is no longer supplying handset buyers a standard wall charger or EarPods, a measure the company says will help offset carbon emissions as part of wider corporate environmental initiatives.

An updated online Apple Store webpage shows EarPods with Lightning Connector now sell for $19, down from $29 prior to iPhone 12’s announcement. A new 20W USB-C wall charger, which stands as a ready replacement for the 18W charger that came with iPhone 11 models, receives the same price reduction to sell for $19.

During today’s iPhone 12 unveiling, Apple Vice President of Environment, Policy and Social Initiatives Lisa Jackson announced the new handset line no longer includes free wall chargers and EarPods, both staples of all iPhone models since the original debuted in 2007. The decision to remove the accessories forwards Apple’s efforts to reduce its impact on the environment, Jackson said.

Read More Read more
model

Tesla reduces Model 3 prices in China and bumps the range with LFP batteries

Tesla has reduced the price of the Model 3 in China and bump the range as it introduces lithium iron phosphate (LFP) batteries.

As we have previously reported, Tesla has been planning to update its made-in-China Model 3 vehicles with lithium iron phosphate (LFP) batteries from Chinese battery maker CATL.

CEO Elon Musk recently mentioned that he believes the energy density of LFP batteries have improved enough that it now makes sense to use the cheaper and cobalt-free batteries in its lower-end vehicles.

Furthermore, the use of LFP batteries also free-up more battery supply of other battery chemistry for Tesla’s other vehicle programs.

After obtaining authorization to build Model 3 with LFP batteries in China earlier this summer, we now learn that Tesla has made the switch and updated its Model 3 lineup in China:

Tesla updated its online Model 3 configurator with the following new prices after incentives:

  • Model
Read More Read more
model

A TLR2 agonist reduces SARS-CoV-2 in upper respiratory tract of ferret model

It is essential to potentiate the human respiratory system’s antiviral immune defenses to reduce severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral shedding in the upper respiratory tract (URT) and control the viral transmission. A prophylactic intranasal administration of the TLR2/6 agonist INNA-051 exhibits viral reduction – this offers a promising approach for possible prevention and management of SARS-CoV-2 infection, particularly useful to individuals at elevated risk of community transmission.

The respiratory virus, SARS-CoV-2, causing the current COVID-19 disease pandemic, initially infects the upper respiratory tract (URT). Infected people may be symptomatic, pre- or asymptomatic, spreading the virus nonetheless. Asymptomatic individuals shed the virus and transmit the disease longer than those with symptoms. It is essential to restrict the initial replication of the virus in URT to prevent the progression of the disease. In a recent bioRxiv* preprint paper, Professor Miles W. Carroll et al. study an agonist for

Read More Read more